Patient-reported outcome data monetization market seen reaching $1.74 billion by 2030

The patient-reported outcome data monetization market is projected to grow from $1.09 billion in 2026 to $1.74 billion by 2030, driven by digital health adoption, electronic health records and demand for real-world patient feedback. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Patient-reported outcome data monetization turns patient-generated health data into a commercial and research asset for providers, payers, drug developers and researchers. - The market’s growth reflects broader healthcare demand for real-world evidence, outcome-based reimbursement and continuous patient monitoring. - The shift could improve clinical decisions, support precision medicine and expand data-driven healthcare business models.

What happened: - The Business Research Company said the patient-reported outcome data monetization market is expected to rise from $0.97 billion in 2025 to $1.09 billion in 2026. - The report projects the market will reach $1.74 billion by 2030. - The 2026-2035 market report covers global size, trends, forecasts and regional opportunities. - The company released a free sample of the report and a full report online: More information and the full report.

The details: - The market’s recent growth has been driven by electronic health records, real-world insights in clinical trials, quality-of-life metrics, patient engagement tools in drug development and regulatory pressure for evidence-based treatments. - The report forecasts a 12.3% CAGR for 2025 to 2026. - It forecasts a 12.5% CAGR from 2026 to 2030. - The technology relies on systems that gather, consolidate, analyze and commercialize patient-reported health data. - The approach uses analytics, artificial intelligence and digital health platforms to collect feedback on symptoms, treatment effectiveness and quality of life. - Digital health platforms such as mobile apps, telehealth services, patient portals and wearables are a key growth driver. - NHS England reported that the NHS App logged 62.3 million uses in November 2025, up 43% from the prior year’s monthly average. - Electronic health records are another major driver because they help providers collect, store and manage patient data in structured, interoperable systems. - The CDC said 95.0% of U.S. office-based physicians had implemented EHR systems by December 2025, and 83.6% used federally certified technology.

Between the lines: - The market’s momentum suggests health data is moving from a clinical record-keeping function toward a monetizable asset class. - Growth in consent management, data ownership rules and standardization points to a market that still needs clearer governance before it scales fully. - The emphasis on value-based reimbursement and shared decision-making shows patient outcomes are becoming a more central commercial and policy metric.

What's next: - The report expects stronger growth from outcome-based reimbursement, precision medicine, health data marketplaces, decentralized and hybrid trials, and real-time patient monitoring. - Emerging themes include regulatory mechanisms for monetization and consent management, ethical frameworks for data ownership and standardized outcome measurement tools. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The bottom line: - Patient-reported outcome data monetization is shifting from a niche digital health segment into a broader healthcare data market, with regulation and interoperability likely to determine how fast it scales.